UK markets open in 6 minutes

Thermo Fisher Scientific Inc. (TMO)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
636.11+8.53 (+1.36%)
At close: 04:00PM EST
635.93 -0.18 (-0.03%)
After hours: 06:41PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 250.66B
Enterprise value 260.34B
Trailing P/E 29.14
Forward P/E 29.50
PEG ratio (5-yr expected) 8.15
Price/sales (ttm)6.39
Price/book (mrq)6.39
Enterprise value/revenue 6.67
Enterprise value/EBITDA 20.19

Trading information

Stock price history

Beta (5Y monthly) 0.72
52-week change 334.52%
S&P500 52-week change 322.93%
52-week high 3666.65
52-week low 3433.52
50-day moving average 3611.31
200-day moving average 3525.60

Share statistics

Avg vol (3-month) 31.35M
Avg vol (10-day) 31.56M
Shares outstanding 5394.05M
Implied shares outstanding 6N/A
Float 8393.22M
% held by insiders 10.21%
% held by institutions 190.10%
Shares short (14 Nov 2021) 42.63M
Short ratio (14 Nov 2021) 42.19
Short % of float (14 Nov 2021) 40.67%
Short % of shares outstanding (14 Nov 2021) 40.67%
Shares short (prior month 14 Oct 2021) 42.6M

Dividends & splits

Forward annual dividend rate 41.04
Forward annual dividend yield 40.17%
Trailing annual dividend rate 31.00
Trailing annual dividend yield 30.16%
5-year average dividend yield 40.26
Payout ratio 44.64%
Dividend date 313 Jan 2022
Ex-dividend date 413 Dec 2021
Last split factor 23:2
Last split date 305 Jun 1996

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)01 Oct 2021

Profitability

Profit margin 21.93%
Operating margin (ttm)27.58%

Management effectiveness

Return on assets (ttm)9.78%
Return on equity (ttm)24.29%

Income statement

Revenue (ttm)39.06B
Revenue per share (ttm)99.01
Quarterly revenue growth (yoy)9.50%
Gross profit (ttm)16.01B
EBITDA 13.28B
Net income avi to common (ttm)8.57B
Diluted EPS (ttm)21.54
Quarterly earnings growth (yoy)-1.60%

Balance sheet

Total cash (mrq)12.03B
Total cash per share (mrq)30.52
Total debt (mrq)21.71B
Total debt/equity (mrq)56.09
Current ratio (mrq)3.19
Book value per share (mrq)98.24

Cash flow statement

Operating cash flow (ttm)10.19B
Levered free cash flow (ttm)6.36B